There is significant need for efficacious membranous nephropathy treatments for high-risk patients (MARKETVUE® REPORT)

Nearly 1 in 5 membranous nephropathy patients never achieve remission, and nearly one-third of those that do will relapse. NEWTON, Mass., May 24, 2023 /PRNewswire/ — Membranous nephropathy (MN) is a rare, autoimmune nephropathy characterized by thickening of the glomerular capillary…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.